<DOC>
	<DOCNO>NCT02998762</DOCNO>
	<brief_summary>The LTFU study conduct naturalistic follow well characterize CAN-BIND study population patient every six month continue five-year period . This provide information longitudinal progress mood , functioning , quality life CAN-BIND sample view towards long-term outcome treatment .</brief_summary>
	<brief_title>Long-Term Follow Up Study</brief_title>
	<detailed_description>This long-term follow study 'Canadian Biomarker Integration Network Depression ' ( CAN-BIND ) study . The CAN-BIND study examines biological marker antidepressant treatment response . The examined biomarkers include clinical , image , genetic component . The Long Term Follow ( LTFU ) study continue follow patient study six month five year period . By , comprehensive clinical outcome data well characterize cohort depress patient obtain . The research team conduct naturalistic study CAN-BIND participant monitor longitudinal progress mood , functioning , quality life , view towards advise future treatment option . Each patient complete CAN-BIND ask participate LTFU study .</detailed_description>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Each patient complete 16 week CANBIND previously meet DSMIVTR criterion Major Depressive Episode ( MDE ) MDD determine MINI . Any Axis I diagnosis , MDD , consider primary diagnosis . Bipolar I Bipolar II diagnosis ( lifetime ) , MDD psychotic feature ( lifetime ) , schizophrenia schizoaffective disorder . Presence significant Axis II diagnosis ( borderline , antisocial ) . High suicidal risk , define clinician judgement . History drug alcohol use , severity least moderate severe , accord DSM criterion , within previous 6 month . Presence significant neurologic disorder , head trauma , unstable medical condition . Subject condition , opinion investigator , participation would interest subject ( e.g . compromise wellbeing ) could prevent , limit , confound protocolspecified assessment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>major depression</keyword>
	<keyword>major depressive disorder</keyword>
	<keyword>biomarkers</keyword>
	<keyword>MDD</keyword>
	<keyword>long term follow</keyword>
</DOC>